Vanguard Health Care ETF (VHT)

Vanguard Health Care ETF (VHT $271.09)
- $271.09 P/E (TTM): 24.74X Cap: $17.64B
- View VHT Profile
- View Questions on VHT

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $453.49)
- $453.49 P/E (TTM): 54.85X Cap: $160.60B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $202.71)
- $202.71 P/E (TTM): 87.33X Cap: $358.54B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $222.51)
- $222.51 P/E (TTM): 20.36X Cap: $535.62B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $974.96)
- $974.96 P/E (TTM): 43.01X Cap: $918.16B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $112.30)
- $112.30 P/E (TTM): 15.6X Cap: $277.36B
- View MRK Profile
- View Questions on MRK
Harvest Healthcare Leaders Income ETF (HHL $6.81)
- $6.81 P/E (TTM): 23.48X Cap: $1.63B
- View HHL Profile
- View Questions on HHL
Vanguard Health Care ETF (VHT $271.09)
- $271.09 P/E (TTM): 24.74X Cap: $17.64B
- View VHT Profile
- View Questions on VHT
Teladoc Health Inc. (TDOC $6.96)
- $6.96 Cap: $1.25B
- View TDOC Profile
- View Questions on TDOC

Q: According to portfolio analytics, I'm seriously underweight in Healthcare, something which I should probably correct. Any of these names herein stick out as great buys in healthcare. US or CAD, no difference to me. Thank you.

Read Answer Asked by Sylvia on April 16, 2026

Eli Lilly and Company (LLY $974.96)
- $974.96 P/E (TTM): 43.01X Cap: $918.16B
- View LLY Profile
- View Questions on LLY
Novo Nordisk A/S (NVO $45.80)
- $45.80 P/E (TTM): 12.42X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
Vanguard Health Care ETF (VHT $271.09)
- $271.09 P/E (TTM): 24.74X Cap: $17.64B
- View VHT Profile
- View Questions on VHT
iShares U.S. Healthcare ETF (IYH $60.95)
- $60.95 P/E (TTM): 24.16X Cap: $2.78B
- View IYH Profile
- View Questions on IYH

Q: I have a > 50% loss on NVO in an RSP, so I'm unable to harvest the tax loss. Do you feel I would break even faster if I, held, sold and bought a US dollar health ETF or LLY? I'm starting to think healthcare ETF, as if I pick the wrong horse, I can end up in the same situation again. What are your recommendations? Healthcare fits in best for my portfolio weightings.

Thanks

Read Answer Asked by Brad on April 09, 2026

iShares Global Healthcare Index ETF (CAD-Hedged) (XHC $65.85)
- $65.85 P/E (TTM): 26.33X Cap: $490M
- View XHC Profile
- View Questions on XHC
State Street Health Care Select Sector SPDR ETF (XLV $144.72)
- $144.72 P/E (TTM): 23.97X Cap: $37.90B
- View XLV Profile
- View Questions on XLV
Vanguard Health Care ETF (VHT $271.09)
- $271.09 P/E (TTM): 24.74X Cap: $17.64B
- View VHT Profile
- View Questions on VHT

Q: Looking to add a health care etf. Which one might you suggest? Would the major difference in performance between the XHC and the other 2 be the currency hedging?

Read Answer Asked by Michael on November 14, 2025